Researchers explore failed SARS-CoV-2 screening at hospital entrances YaleMed SARSCoV2 COVID19 Screening Hospitals
By Pooja Toshniwal PahariaDec 1 2022Reviewed by Aimee Molineux In a recent study published in JAMA Internal Medicine, researchers evaluated the failure rates of coronavirus disease 2019 screening at hospital entrances for visitors, health professionals, and patients at the Yale New Haven Hospital in the United States .
COVID-19 screening was performed at ten entry points of the hospital between 17 March 2020, and 8 May 2021. Failed COVID-19 screening was determined based on the elevated temperature of ≥38 °C, clinical symptoms or exposure indicating SARS-CoV-2 infections, a SARS-CoV-2-positive report in the preceding 14 days, or recent history of visiting high-risk places.
During the initial COVID-19 wave , screening failed for 0.7% of individuals . During the subsequent waves, consistent failure rates of COVID-19 screening were observed during the periods of high COVID-19 incidence and low COVID-19 incidence in community-based settings. In 2020, the total number of individuals screened at the hospital during March, April, May, June, July, August, September, October, November, and December were 5,303 individuals, 16,521 individuals, 22,546 individuals, 50,362 individuals, 76,559 individuals, 80,479 individuals, 94,997 individuals, 99,638 individuals, 74,016 individuals, and 65,196 individuals, respectively.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
The evolutionary trajectories and mechanisms driving the emergence of post-Omicron SARS-CoV-2 lineagesThe evolutionary trajectories and mechanisms driving the emergence of post-Omicron SARS-CoV-2 lineages COVID19 coronavirus covid SARSCoV2 evolution
Lire la suite »
Plasma from vaccinated and COVID-19 convalescent subjects as passive immunotherapy against the new Omicron BQ.1.1, XBB, and BF.7 variantsPlasma from vaccinated and COVID-19 convalescent subjects as passive immunotherapy against the new Omicron BQ.1.1, XBB, and BF.7 variants biorxivpreprint JohnsHopkinsSPH COVID19 vaccinated covid coronavirus Omicron
Lire la suite »
Study shows SARS-CoV-2 VOCs disseminated around the world according to different spatial source-sink dynamicsStudy shows SARS-CoV-2 VOCs disseminated around the world according to different spatial source-sink dynamics medrxivpreprint StellenboschUni UKZN UofT SARSCoV2 COVID19 coronavirus covid
Lire la suite »
Study suggests persistent immune activation and long COVID correlate independently with severe COVID-19Researchers investigated whether severe COVID-19 patients exhibited inflammation and immune activation three months after hospitalization and explored the associations among COVID-19 severity, long COVID, and immune activation.
Lire la suite »
Clinical Outcomes of Pregnant Patients Treated With Nirmatrelvir and Ritonavir for SARS-CoV-2 InfectionThis case series examines the outcomes experienced by pregnant patients prescribed nirmatrelvir and ritonavir to treat SARS-CoV-2 infection.
Lire la suite »
SARS-CoV-2 RNA found to be present in various environmental surface samplesResearchers conducted environmental surveillance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ribonucleic acid (RNA).
Lire la suite »